<header id=042565>
Published Date: 2021-05-06 12:44:56 EDT
Subject: PRO/AH/EDR> COVID-19 update (161): Seychelles, vaccine, Nepal, WHO
Archive Number: 20210506.8348332
</header>
<body id=042565>
CORONAVIRUS DISEASE 2019 UPDATE (161): SEYCHELLES, VACCINE, NEPAL, WHO
**********************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

In this update:
[1] Seychelles
[2] Vaccine: Sinovac
[3] Nepal: Everest base camp
[4] WHO: daily new cases reported (as of 4 May 2021)
[5] Global update: Worldometer accessed 4 May 2021 19:19 EST (GMT-5)

******
[1] Seychelles
[A]. Cases with vaccination
Date: Wed 5 May 2021
Source: BBC [edited]
https://www.bbc.com/news/world-africa-56992121


The Seychelles, which has fully vaccinated over 60% of its population against Covid-19, is bringing back restrictions amid a rise in cases. The archipelago of nearly 100 000 people recorded close to 500 new cases in the 3 days to [1 May 2021] and has about 1000 active cases.

A 3rd of the active cases involved people who had had 2 vaccine doses, the country's news agency said. The rest had either had a single dose or were unvaccinated.

Schools have been closed and sports activities cancelled for 2 weeks. Bars, restaurants and shops are to close early and some gatherings have been banned. "Despite all the exceptional efforts we are making, the Covid-19 situation in our country is critical right now with many daily cases reported last week," health minister Peggy Vidot told a press conference on [Tue 4 May 2021].

More than four-fifths of the active cases were among Seychellois people, with the remainder made up of foreigners.

The Seychelles, which relies on tourism for much of its income, began vaccinating its population in January using Chinese-made Sinopharm vaccine doses donated by the United Arab Emirates. By mid-April [2021] about 60% of the vaccine doses administered in the country were Sinopharm, with the rest Indian-made AstraZeneca vaccine doses, Bloomberg reported.

Trials in China and the United Arab Emirates have put Sinopharm vaccine efficacy at 79% and 86%, respectively. The World Health Organization is expected to approve the Sinopharm vaccine and other Chinese-made vaccines for use later this week. In April [2021], China's top disease control official said the efficacy of the country's Covid vaccines was low, although he later insisted his comments had been misinterpreted.

Researchers in Brazil have put the efficacy of another Chinese-made vaccine, the Sinovac vaccine, at 50.4%.

--
communicated by:
ProMED rapporteur Kunihiko Iizuka

[It would be helpful to know which vaccine the individuals received and their immunization status, who were fully vaccinated but are getting reinfected. It is not clear whether these were unsuccessful vaccinations (Sinopharm is estimated to be 79--86% effective) or whether it is inability of successfully immunized individuals to be protected from infection with variants. A 3rd of the active cases involved people who had 2 vaccine doses, and Sinopharm was used in 60% of the vaccinations, Indian-made AstraZeneca, the remainder. - Mod.LK

HealthMap/ProMED map of Seychelles: https://promedmail.org/promed-post?place=8348332,183]

----
[B] Comment (Daniel R Lucey)
Date: Wed 5 May 2021
Source: Science speak blog [edited]
https://sciencespeaksblog.org/2021/05/05/seychelles-reports-rising-cases-in-vaccinated-and-unvaccinated-global-implications-for-variants-vs-vaccines/


On [Tue 4 May 2021], the Seychelles news agency reported: "There are currently 1068 active cases numbers, among which 84% are Seychellois and 16% are foreigners. Some 65% of the active cases are unvaccinated or have received only one dose, whilst the remaining have taken both doses. To date over 59 600 persons have received both doses of vaccines, representing 85% of the targeted population."

At least 2 vaccines (both requiring 2 doses) have been used: Sinopharm (donated by the UAE) and Covishield (donated by India, and also known as the AstraZeneca vaccine).

Data are not yet available from Seychelles on virus sequencing and variants in [April 2021], especially important in order to compare viruses in persons fully vaccinated (2 doses) vs 1 dose vs. unvaccinated. Nor are data publicly available on the degree of clinical severity in these patients who have been fully or partially vaccinated. A comparison between Sinopharm, Covishield, and unvaccinated infected persons could then be done using genetic sequencing and clinical outcome data.

In February [2021] the variant B.1.351 was confirmed in a small number of patients in Seychelles.

Earlier this year [2021] South Africa decided not to use the AstraZeneca vaccine due to a very low efficacy in preventing infection with the B.1.351 variant initially found in South Africa.

Given the widespread international use of these 2 vaccines there are global implications to what is happening now in the Seychelles e.g., international travel, mass gatherings events whether religious, musical, or the Olympics (Japan July 2021 and China February 2022). The variant B.1.351 or a novel variant must be ruled out as soon as possible by large-scale genetic sequencing, perhaps in the renowned laboratories in South Africa that have been performing sequencing for other nations in Africa.

[byline: Daniel R Lucey]

--
communicated by:
Mary Marshall
<mjm2020@googlemail.com>
with thanks to Dan Lucey

******
[2] Vaccine: Sinovac
Date: Wed 13 Jan 2021 [ProMED regrets the delay in posting]
Source: BBC [edited]
https://www.bbc.com/news/world-latin-america-55642648


A coronavirus vaccine developed by China's Sinovac has been found to be 50.4% effective in Brazilian clinical trials, according to the latest results released by researchers. It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval.

The Chinese vaccine is one of 2 that the Brazilian government has lined up. Brazil has been one of the countries worst affected by Covid-19.

Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response. Several countries, including Indonesia, Turkey and Singapore, have placed orders for the vaccine.

Last week [w/e 10 Jan 2021] researchers at the Butantan Institute, which has been conducting the trials in Brazil, announced that the vaccine had a 78% efficacy against "mild-to-severe" Covid-19 cases. But on Tue [12 Jan 2021] they revealed that calculations for this figure did not include data from a group of "very mild infections" among those who received the vaccine that did not require clinical assistance.

With the inclusion of this data, the efficacy rate is now 50.4%, said researchers. But Butantan stressed that the vaccine is 78% effective in preventing mild cases that needed treatment and 100% effective in staving off moderate to serious cases.

The Sinovac trials have yielded different results across different countries. Last month Turkish researchers said the Sinovac vaccine was 91.25% effective, while Indonesia, which rolled out its mass vaccination programme on [Wed 13 Jan 2021], said it was 65.3% effective. Both were interim results from late-stage trials.

--
communicated by:
ProMED rapporteur Kunihiko Iizuka

[It doesn't appear the Seychelles is going to bring onboard Sinovac vaccine, but its effectiveness is reported to vary depending by country. It is not clear why the range is so large -- that is, from 65.3% (Turkey) successful to 91.25% (Indonesia). - Mod.LK]

******
[3] Nepal: Everest base camp
Date: Wed 5 May 2021
Source: BBC [edited]
https://www.bbc.com/news/world-asia-56984320


Mountaineers and authorities at Everest base camp in Nepal have told the BBC they are seeing rising numbers of climbers with Covid-19 symptoms and rising numbers of positive tests, raising fears of a serious outbreak. Base camp officials said they had received reports of 17 confirmed cases from hospitals in the capital Kathmandu, where a number of climbers have been sent from the base camp and higher camps to be treated.

And staff at a private hospital in Kathmandu, the CIWEC clinic, confirmed to the BBC that patients had tested positive for coronavirus after arriving from Everest base camp.

The Nepalese government has so far denied having any knowledge of positive cases at Everest base camp, raising concerns that officials are downplaying the extent of the situation out of fear it will bring more pressure to close the mountain to expeditions. Foreign climbers are a major source of revenue for the Nepalese government, which shut Everest last year [2020] during the pandemic.

Authorities are mandating that visiting climbers quarantine in Nepal before proceeding to base camp, but concerns have been raised within the climbing community that a serious outbreak at the mountain would be devastating.

The number of coronavirus cases has risen sharply in Nepal in recent weeks, and the country has the highest rate of infection among the countries neighbouring India, where a 2nd wave has sparked a full-blown crisis.

Officials from Nepal's Department of Tourism, which directly oversees expeditions, could not be reached for comment, but Prem Subedi, the under-secretary at Nepal's Ministry of Culture, Tourism and Civil Aviation, told the BBC the ministry was not aware of any coronavirus cases at base camp. "None of the Covid cases at Everest base camp have been reported so far to the Ministry of Tourism," he said.

The Himalayan Rescue Association, which runs a government-authorised medical clinic at the base camp, told the BBC it had received confirmation of positive cases in some climbers flown out to Kathmandu by expedition teams. "We have just received from Kathmandu confirmation of 17 positive cases [in climbers flown out of Everest]," said Lhakpa Nuru Sherpa, an official with the Himalayan Rescue Association. "We have now asked expedition teams to 1st let us know before they fly out their members [to Kathmandu] who fall ill so that we know what is going on," he said.

Lhakpa Nuru Sherpa's colleague at the Everest base camp clinic, Dr Prakash Kharel, said the number of people showing coronavirus-like symptoms, such as a persistent cough and fever, is rising daily. "Almost all climbers get a cough here, but we are seeing people with other symptoms, and we are making sure that they stay in isolation," Dr Kharel said.

The CIWEC clinic in Kathmandu also confirmed to the BBC that it had seen Covid-positive climbers come to them as patients from Everest. "We did have patients come to us from the Everest region who tested positive at our hospital a couple of weeks back," said staff member Astha Pant. "We cannot share how many people or any other information at this time."

One of the big expedition teams, who asked not to be named, told the BBC that some of their members had previously tested positive, but had now recovered. A Norwegian climber, Erlend Ness, told the BBC that he had tested positive for the virus 3 times in 2 different hospitals in Kathmandu last month [April 2021].

Ness was initially thought to be suffering from altitude sickness but was diagnosed with coronavirus after being airlifted from base camp. Climbers have raised fears that coronavirus symptoms would be mistaken for the similar effects of being at altitude. "You can hear people coughing everywhere," Lukas Furtenbach, team leader of Furtenbach Adventures, told the BBC from base camp. "But this is not just the regular cough that mountaineers catch here. You can make it out that people are in pain and they have other symptoms like fever and body aches."

According to the website of the Department of Tourism, the government had issued 394 Everest climbing permits for this climbing season, as of [26 Apr 2021]. That would allow more than 1500 people to be on the mountain, the majority of them support staff.

Officials at Everest base camp said there was also concern over climbers coming back from Kathmandu either after Covid treatment or after acclimatisation rotation to adjust to the altitude. "They may have recovered themselves but they might bring the virus along with them as things are getting serious in Kathmandu," said the army official. "We have therefore recommended that climbers do the rotation acclimatisation at places below the base camp, instead of going to Kathmandu."

Mountaineers and officials at the Everest base camp also said that the lack of a coronavirus testing facility at the base camp health clinic was a major handicap. "We had requested a testing facility but the government said they could not give the permission," said Dr Kharel.

Some of the big expedition teams have said they have brought their own testing kits to Everest base camp, which has helped them to take timely steps like isolating people and evacuating them.

Himalayan Rescue Association officials said they had only recently received the confirmed reports of 17 positive coronavirus cases in climbers from Everest base camp. "It is unfortunate that we have not been receiving the details of the confirmed cases and the identities of the climbers all this time," an army official at the base camp told the BBC. "That would have helped us in contact tracing and containing the spread much earlier," he said. "We could have then isolated the climbers who had come in contact with those who tested positive much earlier."

[byline: Navin Singh Khadka]

--
communicated by:
ProMED rapporteur Kunihiko Iizuka

[This is a big problem with "1500 people to be on the mountain, the majority of them support staff". The Sherpas and tourists both are at risk, and the virus could spread rapidly through both communities as symptoms are not COVID-specific. Furthermore, without testing before beginning a climb, the deprivation of O2 as altitude increases may exacerbate disease pathology as some investigators conclude from other studies, while others felt it is protective. A selection of references follow presenting both perspectives.

Quarantine in Nepal before proceeding to base camp will not prevent spread of the virus already circulating in the camp. This is a situation where rapid tests would be very helpful.

Additional reading:

Millet GP, Debevec T, Brocherie F, Burtscher M, Burtscher J. Altitude and COVID‚Äê19: friend or foe? A narrative review. Physiol Rep. 2020; 8:e14615. https://doi.org/10.14814/phy2.14615
Zubieta-Calleja GR, et al. COVID-19 and pneumolysis simulating extreme high-altitude exposure with altered oxygen transport physiology; multiple diseases, and scarce need of ventilators: Andean condor's-eye-view. Reviews on Recent Clinical Trials. 2020, doi.org/10.2174/1574887115666200925141108.
Stephens KE, Chernyavskiy P, Bruns DR. Impact of altitude on COVID-19 infection and death in the United States: a modeling and observational study. PLoS ONE. 2021, 16(1): e0245055. https://doi.org/10.1371/journal.pone.0245055
- Mod.LK

HealthMap/ProMED map of Nepal: https://promedmail.org/promed-post?place=8348332,139]

******
[4] WHO: daily new cases reported (as of 5 May 2021)
Date: Wed 5 May 2021
Source: WHO [abridged, edited]
https://covid19.who.int/table


*Daily case reports as of 5 May 2021 16:18 CET

Surveillance
------------
WHO region (no. countries/territories):
Total confirmed cases (new cases in last 24 hours) / Total deaths (new deaths in last 24 hours)
----------------------------------------------------------------------
Western Pacific Region (19): 2 522 720 (15 506) / 38 019 (185)
European Region (61): 52 275 954 (132 915) / 1 092 527 (2906)
South East Asia Region (10): 23 837 189 (400 973) / 291 762 (4112)
Eastern Mediterranean Region (22): 9 274 240 (43 369) /185 875 (849)
Region of the Americas (54): 62 713 257 (123 717) / 1 529 597 (3295)
African Region (49): 3 330 385 (4918) / 83 259 (144)
Cases on an international conveyance (Diamond Princess): 745 (0) / 13 (0)

Confirmed cases (new cases in last 24 hours) / Total deaths (new deaths in last 24 hours)
Grand total: 153 954 491 (721 398) / 3 221 052 (11 491)

--
communicated by:
ProMED
<promed@promedmail.org>

[Data by country, area, or territory for 4 May 2021 can be accessed at https://promedmail.org/wp-content/uploads/world-pdf/2021%20WHO%20Daily%20Tables%20May5_1620321995.pdf.

- The Americas region reported 17.1% of daily case numbers and 28.6% of the daily deaths reported in the past 24 hours and maintained its position as the most severely affected region, having reported more than 62.71 million cases. The USA reported over 39 000 cases over the last 24 hours followed by Brazil with 24 619 cases, Argentina (15 920), and Colombia (11 599). 12 additional countries reported more than 1000 cases in the past 24 hours (Canada, Mexico, Peru, Chile, Paraguay, Bolivia, Ecuador, Costa Rica, Venezuela, Cuba, Guatemala, and Uruguay). An additional 2 countries (Venezuela, and Honduras) reported more than 500 but fewer than 1000 cases.

- The European region reported 18.4% of daily case numbers and 25.2% of the daily deaths reported in the past 24 hours, and total cumulative cases reported exceed 52.27 million cases. Many countries not reporting cases in the last 24 hours or longer include Spain, Belgium (1 case), Switzerland (4 cases), and Kazakhstan, among others. Turkey reported the highest number of cases over the last 24 hours, followed by France and Germany, reporting more than 10 000 new cases in the past 24 hours. Another 13 countries reported more than 1000 cases, and an additional 6 countries reported more than 500 but fewer than 1000 cases.

- The Eastern Mediterranean region reported 6% of daily case numbers and 7.3% of the deaths reported in the past 24 hours, having reported a cumulative total of more than 9.27 million cases. Iran reported the highest number of cases (20 150) over the last 24 hours, followed by Iraq, Pakistan, Jordan, UAE, Tunisia, Kuwait, Bahrain, and Egypt. Qatar, Oman, Palestinian Authority, Lebanon, and Saudi Arabia reported more than 500 but fewer than 1000 cases.

- The African region reported 0.6% of daily case numbers and 1.2% of the deaths reported in the past 24 hours, having reported a cumulative total of more than 3.33 million cases. South Africa (1187) reported the highest number of cases over the last 24 hours. Ethiopia (541) reported more than 500 but fewer than 1000 cases. Botswana, Cameroon, Ghana, and Congo among others, did not report any new cases in the past 24 hours.

- The Western Pacific region reported 2.1% of daily case numbers and 1.6% of the deaths reported in the past 24 hours, having reported a cumulative total of more than 2.52 million cases. Philippines reported the highest number of cases over the last 24 hours (over 5000 cases), followed by Japan, Malaysia, Mongolia, and South Korea.

- The South East Asia region reported 55.5% of the daily newly reported cases and 35.7% of reported deaths in the past 24 hours, having reported a cumulative total of more than 23.83 million cases. India is dominant reporting over 382 000 cases, followed by Nepal (7587), Indonesia (4369), Thailand (2112), Sri Lanka(1914), and Bangladesh (1914).

On the Overview tab at the WHO source URL, the epidemic curve of confirmed COVID-19 cases by WHO region, 30 Dec 2019 through 5 May 2021, is an excellent visual representation of the pandemic. - Mod.UBA]

******
[5] Global update: Worldometer accessed 5 May 2021 19:19 EST (GMT-5)
Date: Wed 5 May 2021
Source: Worldometer [edited]
https://www.worldometers.info/coronavirus/#countries


[For those who wish to see the detailed global data, a snapshot of the Worldometer table at the time we accessed it is available at:
https://promedmail.org/wp-content/uploads/world-pdf/2021%20WORLDDATA%20MAY5_1620322091.pdf.

A 7-day series of cumulative data reported by countries, territories, and reporting entities can be found at https://promedmail.org/wp-content/uploads/world-pdf/2021%20MAY5WORLD7_1620322460.pdf. - Mod.UBA]

Total number of reported deaths: 3 255 252
Total number of worldwide cases: 155 819 475
Number of newly confirmed cases in the past 24 hours: 846 422

--
communicated by:
ProMED
<promed@promedmail.org>

[In the past 24 hours, India (412 618), Brazil (75 652), the USA (46 129), and Turkey (26 476) have reported the highest numbers of cases. A global total of 14 228 deaths were reported in the past 24 hours (late 3 May 2021 to late 4 May 2021). Countries reporting more than 10 000 newly confirmed cases in the past 24 hours (10 countries) include India, the USA, Brazil, Turkey, France (26 000), Argentina (24 079), Germany (21 266), Iran (15 872), Colombia (14 806), and Italy (10 576). A total of 66 countries reported more than 1000 cases in the past 24 hours; 37 of the 66 countries are from the European region, 9 are from the Americas region, 9 are from the Eastern Mediterranean region, 5 are from the South East Asia region, 4 are from the Western Pacific region, and 2 from the African region.

Comparing the 7-day averages of daily confirmed cases from the past 7 days and those from 8-14 days ago, case counts have decreased by 1.9%, while daily reported deaths have increased by 1.8%. Similar comparative 7-day averages in the USA show a 13.2% decrease in daily reported cases and 7.7% decrease in reported deaths.

Impression: The global daily reported over 800 000 newly confirmed infections in the past 24 hours with over 155.81 million cumulative reported cases and over 3.25 million reported deaths - Mod.UBA]
See Also
COVID-19 update (160): variants, research, India, WHO 20210505.8346370
COVID-19 update (159): animal, India, zoo, lion 20210504.8344580
COVID-19 update (158): variants Africa, Japan Olympics, Brazil, WHO 20210504.8344376
COVID-19 update (157): India, Africa, Canada, maternal transmission, WHO 20210503.8342612
COVID-19 update (156): India, Africa, spike protein, WHO, global 20210502.8340934
COVID-19 update (155): B1.617, flight trans, Papua New Guinea, SoAs, WHO, global 20210502.8340070
COVID-19 update (154): Israel, vaccines, Asia, UK, WHO, global 20210430.8338358
COVID-19 update (153): impact on children, ischemic stroke, India, WHO, global 20210429.8336312
COVID-19 update (152): animal, Croatia, dog, OIE 20210429.8336058
COVID-19 update (151): India vaccine, variant, USA, weekly update, WHO, global 20210428.8334213
COVID-19 update (150): Nepal, India support, Qatar, Japan updates, WHO, global 20210427.8331945
COVID-19 update (149): medium term outcomes, immune resp., children, WHO, global 20210426.8329778
COVID-19 update (148): India, thrombosis, breakthrough, WHO, global 20210425.8327477
COVID-19 update (147): vaccines, pregnancy, South Asia, WHO, global 20210424.8326482
COVID-19 update (146): nursing home outbreak, variants, India, WHO, global 20210423.8324434
COVID-19 update (145): animal, Italy, mink, OIE 20210422.8322984
COVID-19 update (144): India, J&J vaccine, WHO, global 20210422.8322680
COVID-19 update (143): questions, VITT, ECMO, obesity, WHO, global 20210421.8320358
COVID-19 update (142): brain damage, India, pneumonia Japan, WHO, global 20210420.8318238
COVID-19 update (141): animal, USA (GA) aquarium, otter 20210420.8317717
COVID-19 update (140): animal, Latvia, mink, OIE 20210419.8314796
COVID-19 update (130): antibody evasion, variants, South Asia, WHO, global 20210410.8300187
COVID-19 update (120): animal, Russia, vaccine 20210331.8281241
COVID-19 update (100): antibodies, vaccine, Thailand, Cambodia, WHO, global 20210316.8250009
COVID-19 update (50): UK vaccine study, Brazil reinfection, WHO 20210205.8167161
COVID-19 update (01): variants, vaccine, Thailand, global, WHO 20210101.8062938
2020
---
Undiagnosed pediatric inflammatory syndrome (06): COVID-19, heart, young adults 20200522.7364506
COVID-19 update (562): viral load, UK vacc dose, ECDC, WHO 20201231.8061525
COVID-19 update (01): China, global, EVZD, reporting criteria, WHO 20200213.6984084
Novel coronavirus (42): China, global, COVID-19, SARS-CoV-2, WHO 20200211.6979942
Novel coronavirus (01): China (HU) WHO, phylogenetic tree 20200112.6885385
Undiagnosed pneumonia: China (HU) (10): genome available, Hong Kong surveill. 20200111.6883998
Undiagnosed pneumonia: China (01): (HU) wildlife sales, market closed, RFI 20200102.6866757
2019
---
Undiagnosed pneumonia: China (HU): RFI 20191230.6864153
and other items in the archives
.................................................sb/lk/sh/uba/ao/sh
</body>
